UNSPSC 51282012: Chloramphenicol succinate

This classification denotes a protein synthesis inhibitor and antibiotic with the molecular formula C15H16Cl2N2O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ZCX619U9A1, chemically known as succinic acid, alpha-monoester with d-threo-(-)-2,2-dichloro-n-(beta-hydroxy-alpha-(hydroxymethyl)-p-nitrophenethyl)acetamide but more generally known as chloramphenicol succinate, which bears US NIH Compound Identifier 2709. Most nations, for tariff and trade purposes, schedule chloramphenicol succinate under HS 29414000.

As of Q4 2014, CHLORAMPHENICOL SUCCINATE remains US FDA's Preferred Term for this commodity. SMILES: C1CC(CCC1[C@H]([C@@H](COC(=O)CCC(=O)O)NC(=O)C(CL)CL)O)[N+](=O)[O-].

UNSPSC 51282012 Chloramphenicol succinate, a Commodity code, encompasses individual pharmaceutical products sold into state and local government health systems, hospitals, clinics, and emergency services. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP in January 2026 for generic multi-source pharmaceuticals and OTC products distributed across participating state and local facilities in Minnesota and Oregon, establishing that state and local buyers acquire specific drug products by National Drug Code (NDC) through cooperative purchasing vehicles that aggregate demand across multiple jurisdictions. The scope includes manufacturers supplying individual pharmaceutical products with detailed specifications—NDC codes, SKUs, UPCs, generic descriptions, strength, dosage form, trade names, and packaging configurations—through authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health 110 and 112, Morris & Dickson Co., LLC) with requirement that vendors maintain pricing arrangements, EDI capability, and compliance with current Good Manufacturing Practices (cGMP) and the Drug Supply Chain Security Act (DSCSA). Issuing bodies under this code include state health departments, county health systems, municipal hospitals and clinics, and special-purpose health authorities participating in cooperative purchasing alliances rather than individual jurisdictions acting alone.

Geographic activity centers on the Upper Midwest, with MMCAP representing participating jurisdictions across Minnesota and Oregon. The MMCAP RFP (Solicitation Number S1070000015802) is the sole recent opportunity on record; responses were due March 26, 2026, with questions closing February 18, 2026. The contract structure establishes multiple awards to become effective July 1, 2026, with a two-year term for new vendors and optional extensions at MMCAP's discretion. Evaluation weights pricing competitiveness at 75 percent, with remaining weight distributed across fixed pricing for the contract term (10 percent), price structure flexibility including flat price, net price formats, or WAC-minus options (5 percent combined with administrative requirements), compliance with administrative data format and EDI capability (5 percent each), and agreement to a 3 percent administrative fee (5 percent). No specific dollar values or set-aside designations are disclosed in the solicitation materials, and performance penalties for violations range from $200 to $1,500 per incident.